Back to search

Article

The Role of microRNAs as Potential Biomarkers in Diffuse Large B-Cell Lymphoma

2025-11-12

Abstract excerpt

Diffuse large B-cell lymphoma (DLBCL) is the most common and clinically aggressive subtype of non-Hodgkin lymphoma (NHL). Although novel therapeutic agents, in-cluding rituximab and polatuzumab vedotin, have improved outcomes, almost one-third of patients ultimately develop relapsed or refractory disease. MicroRNAs (miRNAs), a class of endogenous single-stranded RNAs approximately 22 nucleotides in length, play a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
655306a2-341f-5522-b4b5-5b052e731bdc
DOI
10.20944/preprints202511.0744.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The Role of microRNAs as Potential Biomarkers in Diffuse Large B-Cell LymphomaDOI 10.20944/preprints202511.0744.v1
Select a neighboring publication to make it the new centre.